Holm, Johanna B.
France, Michael T.
Gajer, Pawel
Ma, Bing
Brotman, Rebecca M.
Shardell, Michelle
Forney, Larry
Ravel, Jacques
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K01-AI163413, R01-AI116799, U19-AI084044)
National Institute of Nursing Research (R01-NR015495)
Article History
Received: 13 December 2022
Accepted: 7 October 2023
First Online: 30 November 2023
Change Date: 6 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40168-024-01765-5
Declarations
:
: Not applicable.
: Not applicable.
: JR is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. JR is Editor-in-Chief at <i>Microbiome.</i> All other authors declare that they have no competing interests.